ARVO 2017: Audrey Voisin
University of Poitiers – Poitiers, France Using IPS Cells to Develop Molecular Therapy for AMD
Continue Reading
ARVO 2017: Feriel Presswalla
University of Michigan Kellogg Eye Center Automated Quantification of Subcellular Structures in the RPE: Lipid Droplets, Autophagic Vacuoles, and Lipofuscin
Continue Reading
ARVO 2017: Kapil Bharti PhD
Induced stem cells, RPE cells and translational applications for degenerative eye diseases.
Continue Reading
ARVO 2017: Deborah Ferrington PhD
Research into mitochondria function and protein degradation in macular degeneration.
Continue Reading
ARVO: 2017: Paul Baird Phd
Looking at molecular reason for non-response in Anti-VEGF treatment
Continue Reading
ARVO 2017: Jim Handa MD
Identifying pathways that induce vision loss as a consequence of drusen in Age Related Macular Degeneration
Continue Reading
ARVO 2017: Alan Marmorstein, PhD
Explaining Clinical Trials, Requirements, procedure and efficacy for participation.
Continue Reading
ARVO 2017: Alan Marmorstein, PhD
Understanding underlying mechanisms of degenerative diseases
Continue Reading
ARVO 2017: Jack Sullivan, MD, PhD
Jack Sullivan, MD, PhD Development of gene-based therapeutics for retinal and macular degeneration
Continue Reading
ARVO 2017: Ed Boyden, PhD
Ed Boyden, PhD Optogenetics – a method for manipulating the activity of nerve cells using light and cell mapping
Continue Reading
Harvard 2016: Margaret DeAngelis PhD
Moran Eye Center University of Utah School of Medicine Genome-Wide Analysis of Allele Specific Expression Demonstrates the Role of Lipid Metabolism in AMD
Continue Reading
Harvard 2016: Joshua Dunaief MD
Perelman Medical School University of Pennsylvania Roles of iron overload and oxidative stress in the blinding disease age-related macular degeneration
Continue Reading
Harvard 2016: Patricia D’Amore PhD
Schepens Eye Research Institute Massachusetts Eye and Ear The effects of Lipids and Inflamasones on AMD
Continue Reading
Harvard 2016: Silvia Finnemann PhD
Fordham University The RPE Cytoskeleton: Regulating RPE Function and Potency, and Changes with Age-related Oxidative Stress
Continue Reading
Harvard 2016: John Dowling PhD
Harvard University: Department of Molecular and Cellular Biology The Human Fovea and Age-Related Macular Degeneration
Continue Reading
AAO 2016: Hendrik Scholl MD
Department of Ophthalmology, University of Basel & Wilmer Eye Institute at Johns Hopkins University Genetic Testing and Gene Therapy for Stargardt Disease & Macular Degeneration
Continue Reading
AAO 2016: Philip Hessberg MD
Philip Hessburg, MD Detroit Institute of Ophthalmology Eye and the Chip
Continue Reading
AAO 2016: Charles Wykoff MD PhD FACS
Retina Consultants of Houston Houston Methodist Blanton Eye Institute TREX: Monthly vs. Treat and Extend for Neovascular AMD
Continue Reading
AAO 2016: Malini Veerappan
Department of Ophthalmology at Duke University Medical School Localized Precursors to New Onset Geographic Atrophy in AMD
Continue Reading
AAO 2016: Jeffrey Busby
Chief Commercial Officer Advanced Tear Diagnostics http://www.teardiagnostics.com
Continue Reading
AAO 2016: Ronald Gentile MD FACS FASRS
New York Eye and Ear Infirmary of Mount Sinai Patient satisfaction and online reviews.
Continue Reading
AAO 2016: Douglas Jabs MD MBA
Icahn School of Medicine at Mount Sinai Ocular inflammation in patients with HIV and AMD
Continue Reading
AAO 2016: Luca Gualdi MD
D.O.M.A. – Rome, Italy Micro-electrostumulation of the cilliary muscle to restore accommodation in early presbyopic eyes.
Continue Reading
ARVO 2016: Stephen Tsang MD,PhD
Columbia University Department of Ophthalmology Therapeutic Gene Editing
Continue ReadingSelect any channel below to view all posts within that channel:
Recently Added:
Click on the Image Below to Read or Listen to the Latest Issues of Foundation’s Quarterly Newsletter – The Magnifier
Subscribe to receive The MAGNIFIER by Email
